ESTRO 2025 - Abstract Book

S1863

Clinical – Upper GI

ESTRO 2025

Conclusion: To our knowledge, this is the first report of MRgRT in pancreatic adenocarcinoma in Spain. Toxicity, LC and DPFS similar to those describe in the literature. No Grade ≥3 toxicities associated with the treatment observed..

Keywords: MgRT, SMART, pancreas

References: Gonsalves, D.,et al. Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in Spain. Cancers , 16 (9).